Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. The co...
Sanyuan Biotechnology: Shareholder Luxin Capital reduced its holdings by nearly 6 million shares, bringing its stake down to 0.97%
Overview of A-share dividends and stock distributions: 18 stocks have their equity registration today
Sanyuan Biotechnology released its performance for the first three quarters, with a net profit attributable to the parent company of 67.3987 million yuan, a decrease of 16.80%
Sanyuan Biotechnology released its performance for the first half of the year, with a net profit attributable to the parent company of 57.4819 million yuan, an increase of 10.73%
Sanyuan Biotechnology: The company, as a mandatory respondent, is subject to a 450.64% anti-dumping duty
Sanyuan Biotechnology: The company's production license for allulose is in process